Olaf Stuve
University of Texas Southwestern Medical Center
H-index: 80
North America-United States
Top articles of Olaf Stuve
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion | Afsaneh Shirani Olaf Stuve Anne H Cross | 2024/2/1 | |
Inverse Association Between Weight-loss Inducing Anti-hyperglycemic Agents and Multiple Sclerosis: Data Mining of the FDA Adverse Event Reporting System Database (P11-6.001) | Afsaneh Shirani Anne Cross Olaf Stuve | 2024/4/14 | |
Choroid plexus enlargement in acute neuroinflammation is tightly interrelated to the tyrosine receptor signalling | bioRxiv | Felix Luessi Julia Schiffer Gabriel Gonzalez-Escamilla Vinzenz Fleischer Sinah Engel | 2024 |
A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis | Laura Airas Robert A Bermel Tanuja Chitnis Hans-Peter Hartung Jin Nakahara | 2024/4 | |
Cladribine tablets after treatment with natalizumab (CLADRINA)–rationale and design | Therapeutic Advances in Neurological Disorders | Peter V Sguigna Rehana Z Hussain Annette Okai Kyle M Blackburn Lauren Tardo | 2024/4 |
Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database | Therapeutic Advances in Neurological Disorders | Afsaneh Shirani Anne H Cross Olaf Stuve | 2024/4 |
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis | Frontiers in Neurology | Rebecca I Spain Andrea Hildebrand Carin S Waslo William D Rooney Joshua Emmons | 2023/6/8 |
Comparing the Infectious and Neoplastic Adverse Event Profiles of Ocrelizumab and Cladribine Using the FDA Adverse Event Reporting Database (P9-6.009) | Nasrin Rahimian Olaf Stuve Afsaneh Shirani | 2024/4/14 | |
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy | Anthony T Reder Olaf Stuve Stephanie K Tankou Thomas P Leist | 2023/5 | |
Distinctive transcriptomic and epigenomic signatures of bone marrow-derived myeloid cells and microglia in CNS autoimmunity | Proceedings of the National Academy of Sciences | Navid Manouchehri Victor H Salinas Rehana Z Hussain Olaf Stüve | 2023/2/7 |
Biological roles of myeloid cell subsets during CNS inflammation (P2-3.005) | Navid Manouchehri Victor Salinas Rehana Hussain Olaf Stuve | 2023/4/25 | |
Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease | Barbara E Stopschinski Rick A Weideman Danni McMahan David A Jacob Bertis B Little | 2023/2 | |
Design and baseline characteristics of Phase 3, double-blind, randomised trials evaluating the efficacy and safety of evobrutinib versus teriflunomide in relapsing multiple … | Multiple Sclerosis and Related Disorders | Xavier Montalban Patrick Vermersch Douglas L Arnold Amit Bar-Or Bruce AC Cree | 2023/12/1 |
Glial cell transcriptome analyses in 3xTg-AD mice: Effects of aging, disease progression, and anti-Aβ immunotherapy | Aging Brain | Doris Lambracht-Washington Min Fu Navid Manouchehri Linda S Hynan Olaf Stuve | 2023/1/1 |
Perspective: Industry–patient relationships for the promotion of pharmaceutical agents | Therapeutic Advances in Neurological Disorders | Meredith A Bryarly Michael A Rubin Olaf Stuve | 2023/10 |
Conserved Transcriptional Signatures of Microglia in Health and Disease (P2-3.011) | Victor Salinas Navid Manouchehri Rehana Hussain Olaf Stuve | 2023/4/25 | |
Animal models of multiple sclerosis: can they advance future therapies? | Frontiers in Molecular Neuroscience | Tara Maria DeSilva Olaf Stuve | 2023/6/13 |
Extended-interval dosing of natalizumab in NOVA | The Lancet Neurology | Olaf Stüve Bastian Tugemann | 2023/3/1 |
A Long-Term Study Evaluating Safety and Efficacy of Evobrutinib in Relapsing Multiple Sclerosis (LONGEVO) | 2023 Annual Meeting of the Consortium of Multiple Sclerosis Centers | Xavier Montalban Douglas L Arnold Amit Bar-Or Bruce AC Cree Anne Cross | 2023/6/1 |
Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome | Annals of neurology | Darin T Okuda Orhun Kantarci Christine Lebrun‐Frénay Maria Pia Sormani Christina J Azevedo | 2023/3 |
